Closing the Treatment Gap in Allergic Rhinitis: Quality of Life Issues
Faculty: Gary N. Gross, MD
Format: Webcast
Credit Available: a maximum of 0.5 AMA PRA Category 1 Credit ™
Course Description: AR is the sixth most prevalent chronic illness in the United States, affecting up to 30% of adults and 40% of children. Poorly controlled AR, either through patient self-medication or physician undertreatment, can add to the morbidity and economic burden of allergic disease. In this certified CME series, follow the diagnosis and treatment of four unique AR patients, whose stories are presented through brief, Web-based activities, or Webisodes.
Closing the Treatment Gap in Allergic Rhinitis: Classification Schemes and Management Strategies
Faculty: Gary N. Gross, MD
Format: Webcast
Credit Available: a maximum of 0.5 AMA PRA Category 1 Credit ™
Course Description: AR is the sixth most prevalent chronic illness in the United States, affecting up to 30% of adults and 40% of children. Poorly controlled AR, either through patient self-medication or physician undertreatment, can add to the morbidity and economic burden of allergic disease. In this certified CME series, follow the diagnosis and treatment of four unique AR patients, whose stories are presented through brief, Web-based activities, or Webisodes.
Closing the Treatment Gap in Allergic Rhinitis: Differential Diagnosis and Quality of Life Issues
Faculty: Michael S. Blaiss, MD
Format: Webcast
Credit Available: a maximum of 0.5 AMA PRA Category 1 Credit ™
Course Description: AR is the sixth most prevalent chronic illness in the United States, affecting up to 30% of adults and 40% of children. Poorly controlled AR, either through patient self-medication or physician undertreatment, can add to the morbidity and economic burden of allergic disease. In this certified CME series, follow the diagnosis and treatment of four unique allergic rhinitis (AR) patients, whose stories are presented through brief, Web-based activities, or Webisodes.
Closing the Treatment Gap in Allergic Rhinitis: The Risks of Asthma and Other Comorbidities
Faculty: Michael S. Blaiss, MD
Format: Webcast
Credit Available: a maximum of 0.5 AMA PRA Category 1 Credit ™
Course Description: AR is the sixth most prevalent chronic illness in the United States, affecting up to 30% of adults and 40% of children. Poorly controlled AR, either through patient self-medication or physician undertreatment, can add to the morbidity and economic burden of allergic disease. In this certified CME series, follow the diagnosis and treatment of four unique allergic rhinitis (AR) patients, whose stories are presented through brief, Web-based activities, or Webisodes.
The Link Between Allergic Rhinitis and Asthma: Achieving Guidelines-Based Care - Child Case
Faculty: Matthew L. Mintz, MD, FACP, Grant Steen, PhD, Marcello A. Morgan, MD, MPH
Format: Webcast
Course Description: Allergic rhinitis (AR) and asthma are two of the most commonly occurring chronic diseases worldwide. Recent epidemiological surveys, basic research studies, and clinical trials substantiate the relationship between asthma and AR and highlight the need to adequately manage the entire respiratory tract.
Recent treatment guidelines present an integrated view of the upper and lower airways and recommend inhaled glucocorticosteroids (ICS) as the most effective treatment when used topically in the nose and lower airway. Despite safety evidence and published guidelines, however, these agents continue to be underprescribed by physicians and underused by patients. This educational activity will raise awareness of the effectiveness of therapy for control of AR and asthma, discuss risk/benefit considerations when making long-term therapy decisions, and explore monitoring methods for detecting the emergence of any side effects.
